206 related articles for article (PubMed ID: 25380122)
21. Audiological Monitoring in Children Treated with Platinum Chemotherapy.
Fetoni AR; Ruggiero A; Lucidi D; De Corso E; Sergi B; Conti G; Paludetti G
Audiol Neurootol; 2016; 21(4):203-211. PubMed ID: 27286730
[TBL] [Abstract][Full Text] [Related]
22. Incidence and associated risk factors for platinum-induced ototoxicity in pediatric patients.
Waissbluth S; Del Valle Á; Chuang A; Becker A
Int J Pediatr Otorhinolaryngol; 2018 Aug; 111():174-179. PubMed ID: 29958605
[TBL] [Abstract][Full Text] [Related]
23. Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.
Peleva E; Emami N; Alzahrani M; Bezdjian A; Gurberg J; Carret AS; Daniel SJ
Pediatr Blood Cancer; 2014 Nov; 61(11):2012-7. PubMed ID: 24976616
[TBL] [Abstract][Full Text] [Related]
24. Group-Wide, Prospective Study of Ototoxicity Assessment in Children Receiving Cisplatin Chemotherapy (ACCL05C1): A Report From the Children's Oncology Group.
Knight KR; Chen L; Freyer D; Aplenc R; Bancroft M; Bliss B; Dang H; Gillmeister B; Hendershot E; Kraemer DF; Lindenfeld L; Meza J; Neuwelt EA; Pollock BH; Sung L
J Clin Oncol; 2017 Feb; 35(4):440-445. PubMed ID: 27937095
[TBL] [Abstract][Full Text] [Related]
25. Long-term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study.
Weiss A; Sommer G; Kasteler R; Scheinemann K; Grotzer M; Kompis M; Kuehni CE;
Pediatr Blood Cancer; 2017 Feb; 64(2):364-373. PubMed ID: 27650356
[TBL] [Abstract][Full Text] [Related]
26. A comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy.
Clemens E; Brooks B; de Vries ACH; van Grotel M; van den Heuvel-Eibrink MM; Carleton B
PLoS One; 2019; 14(2):e0210646. PubMed ID: 30763334
[TBL] [Abstract][Full Text] [Related]
27. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.
Waissbluth S; Peleva E; Daniel SJ
Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1187-1196. PubMed ID: 27245751
[TBL] [Abstract][Full Text] [Related]
28. Clinical trials, ototoxicity grading scales and the audiologist's role in therapeutic decision making.
King KA; Brewer CC
Int J Audiol; 2018 Sep; 57(sup4):S89-S98. PubMed ID: 29276851
[TBL] [Abstract][Full Text] [Related]
29. Audiologist Practices: Parent Hearing Aid Education and Support.
Meibos A; Muñoz K; White K; Preston E; Pitt C; Twohig M
J Am Acad Audiol; 2016 Apr; 27(4):324-32. PubMed ID: 27115242
[TBL] [Abstract][Full Text] [Related]
30. Ototoxicity prognostic models in adult and pediatric cancer patients: a rapid review.
DeBacker JR; McMillan GP; Martchenke N; Lacey CM; Stuehm HR; Hungerford ME; Konrad-Martin D
J Cancer Surviv; 2023 Feb; 17(1):82-100. PubMed ID: 36729346
[TBL] [Abstract][Full Text] [Related]
31. Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer.
Rajput K; Edwards L; Brock P; Abiodun A; Simpkin P; Al-Malky G
Int J Pediatr Otorhinolaryngol; 2020 Nov; 138():110401. PubMed ID: 33152988
[TBL] [Abstract][Full Text] [Related]
32. New insights into cisplatin ototoxicity.
Brock PR
Cancer; 2022 Jan; 128(1):43-46. PubMed ID: 34490622
[TBL] [Abstract][Full Text] [Related]
33. Current practice of ototoxicity management across the United Kingdom (UK).
Maru D; Malky GA
Int J Audiol; 2018 Sep; 57(sup4):S76-S88. PubMed ID: 29676584
[TBL] [Abstract][Full Text] [Related]
34. Perspectives and practices of ototoxicity monitoring.
Paken J; Govender CD; Pillay M; Sewram V
S Afr J Commun Disord; 2020 May; 67(1):e1-e10. PubMed ID: 32501032
[TBL] [Abstract][Full Text] [Related]
35. The current state of ototoxicity monitoring in New Zealand.
Steffens L; Venter K; O'Beirne GA; Kelly-Campbell R; Gibbs D; Bird P
N Z Med J; 2014 Jul; 127(1398):84-97. PubMed ID: 25146864
[TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid shunting and hearing loss in patients treated for medulloblastoma.
Guillaume DJ; Knight K; Marquez C; Kraemer DF; Bardo DM; Neuwelt EA
J Neurosurg Pediatr; 2012 Apr; 9(4):421-7. PubMed ID: 22462709
[TBL] [Abstract][Full Text] [Related]
37. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy.
Baguley DM; Prayuenyong P
Cancer Chemother Pharmacol; 2020 Feb; 85(2):245-250. PubMed ID: 31865419
[TBL] [Abstract][Full Text] [Related]
38. Incidence of childhood hearing loss after in utero exposure to platinum agents.
Finch LE; Cardonick EH
Prenat Diagn; 2021 Oct; 41(11):1467-1474. PubMed ID: 34462927
[TBL] [Abstract][Full Text] [Related]
39. An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series.
Hollander C; Joubert K; Schellack N
JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14036. PubMed ID: 31934875
[TBL] [Abstract][Full Text] [Related]
40. Applying U.S. national guidelines for ototoxicity monitoring in adult patients: perspectives on patient populations, service gaps, barriers and solutions.
Konrad-Martin D; Poling GL; Garinis AC; Ortiz CE; Hopper J; O'Connell Bennett K; Dille MF
Int J Audiol; 2018 Sep; 57(sup4):S3-S18. PubMed ID: 29157038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
